Schedule 13G ownership disclosure
AYTU BIOPHARMA INC
Security class unavailable · CUSIP: 054754874
Event date: 2020-12-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,333,334
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000693
- Form type
- SC 13G
- Filer
- AYTU BIOPHARMA, INC
- CIK
- CIK 1385818
- Filed
- Dec 17, 2020
- Reporting period
- Dec 11, 2020
- Description
- Schedule 13G beneficial ownership